首页> 外文期刊>Wiener klinische Wochenschrift >Peritoneal dialysis in patients with high body-mass index
【24h】

Peritoneal dialysis in patients with high body-mass index

机译:体重指数高的患者进行腹膜透析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Most physicians do not consider peritoneal dialysis (PD) to be the treatment of choice in obese patients with end-stage renal failure. In some but not all studies the incidence of infectious complications (catheter-associated infections and peritonitis) is higher than in patients with normal body mass index (BMI). Although mathematical models show that even continuous ambulatory PD with a daily dialysate treatment volume of 12 litres does not provide sufficient clearances in patients weighing 80 kg, adequate dialysis has been achieved in clinical studies in patients with BMI up to 46 kg/m2. Residual renal function is a very important factor for survival in patients undergoing PD and might be influenced by body weight; however, data are controversial, showing either a negative influence of high BMI on renal clearance or no association. The incidence of peritoneal leaks in PD is higher in obese patients than in other patients, because of the raised intra-abdominal pressure. In contrast, hernias do not occur more frequently in overweight PD patients and the risk of hernias seems to be greater in patients with lower BMI. It is well known that mortality rates of overweight patients on hemodialysis are lower than in those with normal body weight, but data on the influence of BMI on survival in PD patients are more controversial. In conclusion, there is no evidence that PD is absolutely contraindicated in patients with high BMI, especially if patients have a strong preference for this type of treatment.
机译:大多数医生并不认为腹膜透析(PD)是终末期肾衰竭的肥胖患者的首选治疗方法。在一些但并非全部研究中,传染性并发​​症(与导管相关的感染和腹膜炎)的发生率高于体重指数(BMI)正常的患者。尽管数学模型表明,即使每天透析液治疗量为12升的连续非卧床PD也无法为80 kg体重的患者提供足够的清除率,但在体重不超过46 kg / m2的BMI患者的临床研究中已经实现了足够的透析。残余肾功能是PD患者生存的重要因素,可能受体重影响。但是,数据存在争议,表明高BMI对肾脏清除率有负面影响或无关联。肥胖患者PD腹膜漏的发生率比其他患者高,因为腹腔内压力升高。相比之下,超重PD患者疝气的发生频率不高,而BMI较低的患者疝气的风险似乎更大。众所周知,血液透析中超重患者的死亡率低于体重正常的患者,但有关BMI对PD患者生存率影响的数据争议更大。总之,没有证据表明高BMI的患者绝对不能使用PD,特别是如果患者强烈倾向于这种治疗方法时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号